ConductScience.org, home

Gene · 90427

BMF: Bcl2 modifying factor

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. BMF: Bcl2 modifying factor. Genes, record 90427. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/90427

On this page

Gene

Symbol
BMF
HGNC
Name
Bcl2 modifying factor
HGNC
NCBI Gene ID
90427
NCBI Gene
HGNC ID
HGNC:24132
HGNC
Ensembl
ENSG00000104081
NCBI Gene
Aliases
FLJ00065
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q96LC9Bcl-2-modifying factor1845Ensembl, GeneID, HGNC

Source UniProt

Patents54

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1438695Q96LC9Espacenet
JP 2026004568 A2026-01-1438696Q96LC9Espacenet
JP 2026004568 A2026-01-1438701Q96LC9Espacenet
JP 2026004568 A2026-01-1438702Q96LC9Espacenet
EP 4641202 A22025-10-295224Q96LC9Espacenet
JP 2025062604 A2025-04-148520Q96LC9Espacenet
JP 2025062604 A2025-04-148521Q96LC9Espacenet
JP 2025062604 A2025-04-148524Q96LC9Espacenet
JP 2025062604 A2025-04-148525Q96LC9Espacenet
KR 1020250017231 A2025-02-045224Q96LC9Espacenet

1 to 10 of 54

See all 54 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,100

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleBMF papersNewest fiscal year
P30CA016672Cancer Center Support Grant152025
P30CA008748Cancer Center Support Grant92025
P30CA056036Translational Research in Cancer72025
P30CA076292Moffitt Cancer Center Support Grant72025
P30CA015083Mayo Clinic Comprehensive Cancer Center Support Grant62025
P30CA021765Cancer Center Support Grant (CCSG)62025
P01CA066996Development of Novel Therapeutic Strategies in Human Leukemias52025
P30CA046934University of Colorado Cancer Center Support Grant52025
P30CA013696Cancer Center Support Grant32025
P30CA014520UW Comprehensive Cancer Center Support32025

1 to 10 of 1,100Source NIH's project files

See all 1,100 nih grants

Papers1,838

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Glucocorticoid receptor activation reorganizes Wnt/LEF1 regulatory circuitry associated with therapeutic response in B-cell acute lymphoblastic leukemia.bioRxiv202642818321PubTator, text miningPubMed
Identification of Inflammatory Cell Death-Related Prognostic Signature and Its Regulatory Mechanism in Lung Adenocarcinoma.Cancer Med202642760759PubTator, text miningPubMed
Comprehensive bioinformatic analyses identify a PANoptosome-related gene diagnostic signature in keloid fibroblasts.Burns202642607510PubTator, text miningPubMed
Apoptotic Signaling Across Breast Cancer Subtypes and Cryoablation-Induced Tissue Injury.Int J Mol Sci202642352901PubTator, text miningPubMed
Oxidative stress-preconditioned exosomes target BMF to restore mitophagy for alleviating intervertebral disc degeneration.Autophagy202642329074PubTator, text miningPubMed
ATRX loss in sarcomas is associated with dysregulated gene and transposable element expression, loss of DNA methylation, and worse survival.ESMO Rare Cancers202641994103PubTator, text miningPubMed
Targeting BCL-xL in Myeloid Malignancies: From Inhibitors to PROTAC.J Cell Mol Med202641937490PubTator, text miningPubMed
Recurrence of focal segmental glomerulosclerosis: An updated review of pathophysiology, biomarkers, and therapeutic strategies.Cell Transplant202641906863PubTator, text miningPubMed
BMP4-driven morphogenetic reprogramming sustains EGFR-TKI resistance via SOX2 suppression and EMT activation.Biomed Pharmacother202641904893PubTator, text miningPubMed
Reactive oxygen species (ROS) in cancer: from mechanism to therapeutic implications.Signal Transduct Target Ther202641881983PubTator, text miningPubMed

1 to 10 of 1,838

See all 1,838 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/90427

GET https://conductscience.org/api/genes/v1/90427/patents?page=2